Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Study suggests lipid droplet accumulation is a conserved feature of senescent cells

A new research paper was published in Volume 18 of Aging on July 1, 2026, titled "Senescent cells accumulate lipid droplets."

16 Jul 2026

Sleeping longer may signal early Alzheimer's-related brain changes

Regularly sleeping long hours each night is associated with higher levels of an Alzheimer's-related protein in the blood, even accounting for other health factors, suggests a new study from UT Health San Antonio, the academic health center of The University of Texas at San Antonio.

15 Jul 2026

Brain’s immune cells play key role in maintaining stability of neuronal networks in Alzheimer's disease

Researchers at Trinity College Dublin have discovered that microglia – the main immune cells of the brain – play a critical role in maintaining the stability of neuronal networks in Alzheimer's disease.

15 Jul 2026

Self-assembling antibody drugs successfully target multiple cancer receptors

Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drug, often given to patients for whom standard chemotherapy has not worked.

15 Jul 2026

Study sheds light on the prognostic value of blood test for predicting cognitive impairment risk

A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged around the extent to which such tests can accurately predict whether a cognitively healthy individual will go on to develop cognitive impairment-a key symptom of Alzheimer's disease.

15 Jul 2026

New report highlights top ten brain health breakthroughs for clinicians

"Understanding Breakthroughs in Brain Health: Top 10 Articles of 2025" - the latest "Top 10" report in the Gerontological Society of America's Insights & Implications in Gerontology series - presents a curated collection of the year's most impactful research on cognitive decline, dementia detection, and brain health across the lifespan, with a focus on actionable insights for primary care providers.

14 Jul 2026

Poor sleep alters brain communication networks differently across adult lifespan

Have trouble sleeping? The reason may depend in part on your age. A recent study including psychology researchers from Binghamton University, State University of New York investigates how poor sleep alters brain communication across the adult lifespan, specifically examining how these changes vary by age and biological sex.

14 Jul 2026

Medical THC and CBD formulation significantly reduces late-life dementia agitation

In a first-of-its-kind clinical trial, U.S. researchers have found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana – THC and CBD – had significantly less agitation compared to people who received a placebo.

14 Jul 2026

Family caregiving drives majority of dementia-related costs across Europe

Researchers found that 58% of total dementia-related costs are linked to unpaid care provided by family members, friends and other informal caregivers, highlighting the substantial burden of dementia beyond healthcare systems alone.

13 Jul 2026

Global consortium releases AI toolbox to unlock new Alzheimer's treatments

The Consortium for Biomedical Research and Artificial Intelligence in Neurodegeneration (C-BRAIN), a global collaboration of academic researchers, pharmaceutical companies, and philanthropic organizations of which Washington University School of Medicine in St. Louis is a founding member, today launched three open-source AI tools to accelerate research aimed at developing new treatments for Alzheimer's disease and other neurodegenerative diseases.

13 Jul 2026

Wearable forehead patch tracks brain-water shifts during sleep at home

A soft, wireless NIRS forehead patch tracked water-sensitive brain signals during 16 overnight home sleep recordings in four healthy men. The signals changed with EEG/EOG-defined sleep stages, suggesting a new way to study sleep-linked brain-fluid dynamics, although the device did not directly measure CSF flow or glymphatic clearance.

9 Jul 2026

Damaged myelin alters sleep brain rhythms in neurological diseases

Scientists have discovered how damage to the myelin sheath – the insulating layer around nerve fibres – affects brain activity during sleep.

9 Jul 2026

Study reveals complex relationship between alcohol and Alzheimer's disease

Alcohol use has been associated with an increased risk of cognitive decline and dementia. But new research from the Texas A&M University Naresh K. Vashisht College of Medicine at Texas A&M Health suggests the relationship between alcohol and Alzheimer's disease is more complicated than previously thought.

9 Jul 2026

Early-onset dementia lowers work productivity years before formal diagnosis

People diagnosed with early-onset dementia had reduced work productivity up to 15 years before diagnosis, according to a study published July 8, 2026, in Neurology, the medical journal of the American Academy of Neurology.

9 Jul 2026

New global Alzheimer’s disease country insights tool reveals major inequalities in diagnosis, treatment access and preparedness across countries

Alzheimer’s Disease International (ADI) has launched the Alzheimer’s Disease Atlas (AD Atlas), a first of its kind platform highlighting how countries diagnose, treat and support people living with dementia.

9 Jul 2026

Study advances understanding of mixed protein pathologies in dementia

The aging brain frequently harbors multiple protein pathologies that contribute to Alzheimer's, Parkinson's and other neurodegenerative diseases.

8 Jul 2026

Study identifies new target for Parkinson's disease neuroprotection

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

8 Jul 2026

Weill Cornell Medicine receives federal grant to study new gene therapy for Alzheimer's disease

The National Institute on Aging of the National Institutes of Health has awarded a five-year grant initially worth $8.37 million for Weill Cornell Medicine researchers to study a new gene therapy for Alzheimer's disease in people who have a high genetic risk of developing the condition.

8 Jul 2026

NFL players have higher rates of neurodegenerative disease-caused mortality

Mass General Brigham, Boston University, and the Concussion & CTE Foundation cohort study of nearly 20,000 NFL players reveals that players are dying of dementia and Parkinson's disease at much higher rates than the general population.

8 Jul 2026

Investigational drug ameliorates neuronal DNA damage and inflammation in Alzheimer's model

Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease.

8 Jul 2026

Alzheimer's Disease News and Research

Further Reading

Study suggests lipid droplet accumulation is a conserved feature of senescent cells

Sleeping longer may signal early Alzheimer's-related brain changes

Brain’s immune cells play key role in maintaining stability of neuronal networks in Alzheimer's disease

Self-assembling antibody drugs successfully target multiple cancer receptors

Study sheds light on the prognostic value of blood test for predicting cognitive impairment risk

New report highlights top ten brain health breakthroughs for clinicians

Poor sleep alters brain communication networks differently across adult lifespan

Medical THC and CBD formulation significantly reduces late-life dementia agitation

Family caregiving drives majority of dementia-related costs across Europe

Global consortium releases AI toolbox to unlock new Alzheimer's treatments

Wearable forehead patch tracks brain-water shifts during sleep at home

Damaged myelin alters sleep brain rhythms in neurological diseases

Study reveals complex relationship between alcohol and Alzheimer's disease

Early-onset dementia lowers work productivity years before formal diagnosis

New global Alzheimer’s disease country insights tool reveals major inequalities in diagnosis, treatment access and preparedness across countries

Study advances understanding of mixed protein pathologies in dementia

Study identifies new target for Parkinson's disease neuroprotection

Weill Cornell Medicine receives federal grant to study new gene therapy for Alzheimer's disease

NFL players have higher rates of neurodegenerative disease-caused mortality

Investigational drug ameliorates neuronal DNA damage and inflammation in Alzheimer's model

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News